Integrated Freight & Logistics
Compare Stocks
4 / 10Stock Comparison
CYRX vs XPOF vs LQDA vs PLNT
Revenue, margins, valuation, and 5-year total return — side by side.
Leisure
Biotechnology
Leisure
CYRX vs XPOF vs LQDA vs PLNT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Integrated Freight & Logistics | Leisure | Biotechnology | Leisure |
| Market Cap | $641M | $244M | $3.67B | $3.52B |
| Revenue (TTM) | $183M | $299M | $69M | $1.38B |
| Net Income (TTM) | $77M | $-34M | $-122M | $229M |
| Gross Margin | 47.2% | 83.2% | 89.4% | 54.2% |
| Operating Margin | -20.2% | 7.8% | -155.0% | 29.6% |
| Forward P/E | 9.1x | 10.9x | 17.5x | 13.0x |
| Total Debt | $231M | $525M | $122M | $443M |
| Cash & Equiv. | $250M | $46M | $176M | $346M |
CYRX vs XPOF vs LQDA vs PLNT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 21 | May 26 | Return |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | 100 | 20.7 | -79.3% |
| Xponential Fitness,… (XPOF) | 100 | 55.8 | -44.2% |
| Liquidia Corporation (LQDA) | 100 | 1838.3 | +1738.3% |
| Planet Fitness, Inc. (PLNT) | 100 | 58.5 | -41.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CYRX vs XPOF vs LQDA vs PLNT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CYRX carries the broadest edge in this set and is the clearest fit for value and quality.
- Lower P/E (9.1x vs 13.0x)
- 42.2% margin vs LQDA's -176.0%
- 10.3% ROA vs LQDA's -44.2%, ROIC -5.1% vs -5.0%
XPOF is the clearest fit if your priority is income & stability.
- Dividend streak 0 yrs, beta 1.94, yield 2.5%
- 2.5% yield, vs PLNT's 0.0%, (2 stocks pay no dividend)
LQDA is the clearest fit if your priority is long-term compounding and sleep-well-at-night.
- 280.9% 10Y total return vs CYRX's 5.6%
- Lower volatility, beta 1.24, current ratio 4.43x
- +172.2% vs PLNT's -56.7%
PLNT is the #2 pick in this set and the best alternative if growth exposure and defensive is your priority.
- Rev growth 12.1%, EPS growth 31.0%, 3Y rev CAGR 12.2%
- Beta 0.31, yield 0.0%, current ratio 2.11x
- 12.1% revenue growth vs CYRX's -24.5%
- Beta 0.31 vs XPOF's 1.94
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 12.1% revenue growth vs CYRX's -24.5% | |
| Value | Lower P/E (9.1x vs 13.0x) | |
| Quality / Margins | 42.2% margin vs LQDA's -176.0% | |
| Stability / Safety | Beta 0.31 vs XPOF's 1.94 | |
| Dividends | 2.5% yield, vs PLNT's 0.0%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +172.2% vs PLNT's -56.7% | |
| Efficiency (ROA) | 10.3% ROA vs LQDA's -44.2%, ROIC -5.1% vs -5.0% |
CYRX vs XPOF vs LQDA vs PLNT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CYRX vs XPOF vs LQDA vs PLNT — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
LQDA leads in 2 of 6 categories
XPOF leads 1 • CYRX leads 1 • PLNT leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
LQDA leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PLNT is the larger business by revenue, generating $1.4B annually — 20.0x LQDA's $69M. CYRX is the more profitable business, keeping 42.2% of every revenue dollar as net income compared to LQDA's -176.0%. On growth, LQDA holds the edge at +11.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $183M | $299M | $69M | $1.4B |
| EBITDAEarnings before interest/tax | -$10M | $35M | -$106M | $568M |
| Net IncomeAfter-tax profit | $77M | -$34M | -$122M | $229M |
| Free Cash FlowCash after capex | -$18M | -$3M | -$108M | $267M |
| Gross MarginGross profit ÷ Revenue | +47.2% | +83.2% | +89.4% | +54.2% |
| Operating MarginEBIT ÷ Revenue | -20.2% | +7.8% | -155.0% | +29.6% |
| Net MarginNet income ÷ Revenue | +42.2% | -11.3% | -176.0% | +16.5% |
| FCF MarginFCF ÷ Revenue | -9.7% | -1.1% | -155.8% | +19.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +16.5% | -21.0% | +11.2% | +21.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +10.7% | +79.1% | +86.4% | +30.0% |
Valuation Metrics
XPOF leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 9.1x trailing earnings, CYRX trades at a 46% valuation discount to PLNT's 16.8x P/E. On an enterprise value basis, PLNT's 6.6x EV/EBITDA is more attractive than XPOF's 7.9x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $641M | $244M | $3.7B | $3.5B |
| Enterprise ValueMkt cap + debt − cash | $621M | $723M | $3.6B | $3.6B |
| Trailing P/EPrice ÷ TTM EPS | 9.11x | -4.45x | -25.47x | 16.80x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 10.90x | 17.54x | 13.04x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 1.80x |
| EV / EBITDAEnterprise value multiple | — | 7.89x | — | 6.57x |
| Price / SalesMarket cap ÷ Revenue | 3.64x | 0.78x | 262.27x | 2.66x |
| Price / BookPrice ÷ Book value/share | 1.27x | — | 43.06x | — |
| Price / FCFMarket cap ÷ FCF | — | 9.86x | — | 13.82x |
Profitability & Efficiency
CYRX leads this category, winning 3 of 9 comparable metrics.
Profitability & Efficiency
CYRX delivers a 16.2% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-6 for LQDA. CYRX carries lower financial leverage with a 0.46x debt-to-equity ratio, signaling a more conservative balance sheet compared to LQDA's 1.58x. On the Piotroski fundamental quality scale (0–9), PLNT scores 9/9 vs LQDA's 1/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +16.2% | — | -5.5% | — |
| ROA (TTM)Return on assets | +10.3% | -9.5% | -44.2% | +7.4% |
| ROICReturn on invested capital | -5.1% | +75.0% | -5.0% | +35.2% |
| ROCEReturn on capital employed | -6.2% | +30.3% | -84.1% | +14.2% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 | 1 | 9 |
| Debt / EquityFinancial leverage | 0.46x | — | 1.58x | — |
| Net DebtTotal debt minus cash | -$20M | $479M | -$54M | $97M |
| Cash & Equiv.Liquid assets | $250M | $46M | $176M | $346M |
| Total DebtShort + long-term debt | $231M | $525M | $122M | $443M |
| Interest CoverageEBIT ÷ Interest expense | -16.64x | -0.24x | -4.63x | 6.73x |
Total Returns (Dividends Reinvested)
LQDA leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LQDA five years ago would be worth $159,547 today (with dividends reinvested), compared to $2,024 for CYRX. Over the past 12 months, LQDA leads with a +172.2% total return vs PLNT's -56.7%. The 3-year compound annual growth rate (CAGR) favors LQDA at 77.2% vs XPOF's -39.1% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +33.5% | -18.5% | +34.6% | -59.9% |
| 1-Year ReturnPast 12 months | +125.4% | -22.6% | +172.2% | -56.7% |
| 3-Year ReturnCumulative with dividends | -42.5% | -77.4% | +456.3% | -38.9% |
| 5-Year ReturnCumulative with dividends | -79.8% | -46.6% | +1495.5% | -42.9% |
| 10-Year ReturnCumulative with dividends | +557.7% | -46.6% | +280.9% | +203.6% |
| CAGR (3Y)Annualised 3-year return | -16.9% | -39.1% | +77.2% | -15.1% |
Risk & Volatility
Evenly matched — CYRX and PLNT each lead in 1 of 2 comparable metrics.
Risk & Volatility
PLNT is the less volatile stock with a 0.31 beta — it tends to amplify market swings less than XPOF's 1.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CYRX currently trades 96.1% from its 52-week high vs PLNT's 38.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.84x | 1.94x | 1.24x | 0.31x |
| 52-Week HighHighest price in past year | $13.28 | $11.14 | $46.67 | $114.47 |
| 52-Week LowLowest price in past year | $5.31 | $3.83 | $11.85 | $37.03 |
| % of 52W HighCurrent price vs 52-week peak | +96.1% | +58.7% | +90.6% | +38.4% |
| RSI (14)Momentum oscillator 0–100 | 77.2 | 48.4 | 65.2 | 32.8 |
| Avg Volume (50D)Average daily shares traded | 468K | 626K | 1.1M | 1.8M |
Analyst Outlook
Evenly matched — CYRX and XPOF each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CYRX as "Buy", XPOF as "Buy", LQDA as "Buy", PLNT as "Buy". Consensus price targets imply 170.8% upside for PLNT (target: $119) vs -2.0% for CYRX (target: $13). XPOF is the only dividend payer here at 2.50% yield — a key consideration for income-focused portfolios.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $12.50 | $8.00 | $50.67 | $119.17 |
| # AnalystsCovering analysts | 18 | 14 | 7 | 26 |
| Dividend YieldAnnual dividend ÷ price | — | +2.5% | — | +0.0% |
| Dividend StreakConsecutive years of raises | 1 | 0 | — | 0 |
| Dividend / ShareAnnual DPS | — | $0.16 | — | $0.02 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.6% | 0.0% | 0.0% | +14.2% |
LQDA leads in 2 of 6 categories (Income & Cash Flow, Total Returns). XPOF leads in 1 (Valuation Metrics). 2 tied.
CYRX vs XPOF vs LQDA vs PLNT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CYRX or XPOF or LQDA or PLNT a better buy right now?
For growth investors, Planet Fitness, Inc.
(PLNT) is the stronger pick with 12. 1% revenue growth year-over-year, versus -24. 5% for Cryoport, Inc. (CYRX). Cryoport, Inc. (CYRX) offers the better valuation at 9. 1x trailing P/E, making it the more compelling value choice. Analysts rate Cryoport, Inc. (CYRX) a "Buy" — based on 18 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CYRX or XPOF or LQDA or PLNT?
On trailing P/E, Cryoport, Inc.
(CYRX) is the cheapest at 9. 1x versus Planet Fitness, Inc. at 16. 8x. On forward P/E, Xponential Fitness, Inc. is actually cheaper at 10. 9x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — CYRX or XPOF or LQDA or PLNT?
Over the past 5 years, Liquidia Corporation (LQDA) delivered a total return of +1495%, compared to -79.
8% for Cryoport, Inc. (CYRX). Over 10 years, the gap is even starker: CYRX returned +557. 7% versus XPOF's -46. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CYRX or XPOF or LQDA or PLNT?
By beta (market sensitivity over 5 years), Planet Fitness, Inc.
(PLNT) is the lower-risk stock at 0. 31β versus Xponential Fitness, Inc. 's 1. 94β — meaning XPOF is approximately 520% more volatile than PLNT relative to the S&P 500. On balance sheet safety, Cryoport, Inc. (CYRX) carries a lower debt/equity ratio of 46% versus 158% for Liquidia Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — CYRX or XPOF or LQDA or PLNT?
By revenue growth (latest reported year), Planet Fitness, Inc.
(PLNT) is pulling ahead at 12. 1% versus -24. 5% for Cryoport, Inc. (CYRX). On earnings-per-share growth, the picture is similar: Cryoport, Inc. grew EPS 163. 3% year-over-year, compared to -37. 2% for Liquidia Corporation. Over a 3-year CAGR, PLNT leads at 12. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CYRX or XPOF or LQDA or PLNT?
Cryoport, Inc.
(CYRX) is the more profitable company, earning 39. 9% net margin versus -931. 7% for Liquidia Corporation — meaning it keeps 39. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PLNT leads at 29. 8% versus -866. 6% for LQDA. At the gross margin level — before operating expenses — PLNT leads at 82. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CYRX or XPOF or LQDA or PLNT more undervalued right now?
On forward earnings alone, Xponential Fitness, Inc.
(XPOF) trades at 10. 9x forward P/E versus 17. 5x for Liquidia Corporation — 6. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PLNT: 170. 8% to $119. 17.
08Which pays a better dividend — CYRX or XPOF or LQDA or PLNT?
In this comparison, XPOF (2.
5% yield) pays a dividend. CYRX, LQDA, PLNT do not pay a meaningful dividend and should not be held primarily for income.
09Is CYRX or XPOF or LQDA or PLNT better for a retirement portfolio?
For long-horizon retirement investors, Planet Fitness, Inc.
(PLNT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 31), +203. 6% 10Y return). Cryoport, Inc. (CYRX) carries a higher beta of 1. 84 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (PLNT: +203. 6%, CYRX: +557. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CYRX and XPOF and LQDA and PLNT?
These companies operate in different sectors (CYRX (Industrials) and XPOF (Consumer Cyclical) and LQDA (Healthcare) and PLNT (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CYRX is a small-cap deep-value stock; XPOF is a small-cap quality compounder stock; LQDA is a small-cap quality compounder stock; PLNT is a small-cap deep-value stock. XPOF pays a dividend while CYRX, LQDA, PLNT do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.